Chiesi Company Profile
✉ Email this page to a colleague
What is the competitive landscape for CHIESI, and what generic alternatives to CHIESI drugs are available?
CHIESI has fifteen approved drugs.
There are forty-eight US patents protecting CHIESI drugs.
There are three hundred and four patent family members on CHIESI drugs in forty-one countries and fifty-three supplementary protection certificates in eighteen countries.
Summary for Chiesi
International Patents: | 304 |
US Patents: | 48 |
Tradenames: | 16 |
Ingredients: | 10 |
NDAs: | 15 |
Patent Litigation for Chiesi: | See patent lawsuits for Chiesi |
Drugs and US Patents for Chiesi
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chiesi | JUXTAPID | lomitapide mesylate | CAPSULE;ORAL | 203858-005 | Apr 23, 2015 | DISCN | Yes | No | 8,618,135 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Chiesi | MYCAPSSA | octreotide acetate | CAPSULE, DELAYED RELEASE;ORAL | 208232-001 | Jun 26, 2020 | RX | Yes | Yes | 10,695,397 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Chiesi | JUXTAPID | lomitapide mesylate | CAPSULE;ORAL | 203858-006 | Apr 23, 2015 | DISCN | Yes | No | 7,932,268 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Chiesi
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Chiesi | FERRIPROX | deferiprone | TABLET;ORAL | 021825-001 | Oct 14, 2011 | 7,049,328 | ⤷ Try a Trial |
Chiesi | CARDENE SR | nicardipine hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 020005-003 | Feb 21, 1992 | 3,985,758 | ⤷ Try a Trial |
Chiesi | JUXTAPID | lomitapide mesylate | CAPSULE;ORAL | 203858-004 | Apr 23, 2015 | 6,492,365 | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for CHIESI drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | Injection | 0.1 mg/mL, 200 mL and0.2mg/mL, 200 mL | ➤ Subscribe | 2013-06-20 |
➤ Subscribe | Tablets | 500 mg | ➤ Subscribe | 2016-01-29 |
➤ Subscribe | Injection | 2.5 mg/mL, 10 mL Ampoules | ➤ Subscribe | 2006-12-27 |
➤ Subscribe | Inhalation Solution | 300 mg/4 mL | ➤ Subscribe | 2017-08-31 |
International Patents for Chiesi Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
New Zealand | 763555 | ⤷ Try a Trial |
Croatia | P20130115 | ⤷ Try a Trial |
Colombia | 2020006242 | ⤷ Try a Trial |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Chiesi Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
1280520 | C300722 | Netherlands | ⤷ Try a Trial | PRODUCT NAME: TOBRAMYCINE OF EEN FARMACEUTISCH AANVAARDBAAR ZOUT DAARVAN; REGISTRATION NO/DATE: C(2011)5394 20110720 |
0726894 | C300520 | Netherlands | ⤷ Try a Trial | PRODUCT NAME: CLEVIDIPINE; NAT. REGISTRATION NO/DATE: RVG 104771 20111129; FIRST REGISTRATION: PL 16881/0003 20111123 |
1725234 | 2014C/002 | Belgium | ⤷ Try a Trial | PRODUCT NAME: LOMITAPIDE ET TOUTE FORME THERAPEUTIQUEMENT EQUIVALENTE TELLE QUE PROTEGEE PAR LE BREVET DE BASE; AUTHORISATION NUMBER AND DATE: EU/1/13/851/001 20130805 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.